Development and evaluation of a liquid chromatography-mass spectrometry assay and its application for the assessment of renal function |
| |
Authors: | Denis M C Venne K Lesiège D Francoeur M Groleau S Guay M Cusson J Furtos A |
| |
Institution: | Université de Sherbrooke, Faculté de Médecine et des Sciences de la santé, 3001, 12(e) Avenue Nord, Sherbrooke, Canada J1H 5N4. |
| |
Abstract: | In the present study we evaluated two commonly used iodinated contrast agents, iohexol and iodixanol, as potential markers of impaired renal function. A reversed phase LC-MS method has been developed in order to separate and quantify the two substances. The assay was linear between 0.02 and 9.7 micromol/L for iohexol and between 0.4 and 49.3 micromol/L for iodixanol (r(2) > 0.998). The recovery during sample preparation ranged from 89.1 to 112.4%. The intra- and inter-assay RSD values were 3.06-13.6% for iohexol and 4.32-12.7% for iodixanol. The validated method was subsequently applied to 17 patients scheduled for angiographic procedure displaying normal and impaired renal function. A mixture of iohexol and iodixanol was intra-arterially injected and their corresponding plasma levels were determined periodically over a 24h period following administration. The elimination of both contrast agents followed by the LC-MS approach allowed us to discriminate between patients with normal and impaired renal function at 4, 8 and 24h after administration. Our preliminary results support the predictive value of iohexol and/or iodixanol clearance in a clinical environment to screen and identify patients at risk of developing CIN. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|